DCM
BMY icon

Dorato Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Dorato Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3K Hold
300
– – 0.01% 220
2026
Q1 		$17.8K Hold
300
– – 0.01% 213
2025
Q4 		$17.1K Buy
+300
New +$14.4K 0.01% 218

Other funds holding BMY

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Dorato Capital Management's BMY Position: Q2 2026 in Review

Dorato Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 300 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #220.

Dorato Capital Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $17.8K in Q1 2026. 1,501 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Dorato Capital Management held 300 shares of Bristol-Myers Squibb worth $17.3K as of Q2 2026.
  • Dorato Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Dorato Capital Management's portfolio in Q2 2026, its #220 holding.
  • Dorato Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Dorato Capital Management's Bristol-Myers Squibb position peaked at $17.8K in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dorato Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.